Aspen Aerogels Past Earnings Performance
Past criteria checks 0/6
Aspen Aerogels's earnings have been declining at an average annual rate of -27.1%, while the Chemicals industry saw earnings growing at 13.9% annually. Revenues have been growing at an average rate of 13.6% per year.
Key information
-27.1%
Earnings growth rate
-8.3%
EPS growth rate
| Chemicals Industry Growth | 12.9% |
| Revenue growth rate | 13.6% |
| Return on equity | -9.4% |
| Net Margin | -19.2% |
| Next Earnings Update | 01 May 2024 |
Recent past performance updates
Recent updates
Health Check: How Prudently Does Aspen Aerogels (NYSE:ASPN) Use Debt?
Apr 05
Aspen Aerogels: Impressive And Intriguing
Mar 25Aspen Aerogels, Inc. (NYSE:ASPN) Looks Just Right With A 53% Price Jump
Mar 08Analysts Have Made A Financial Statement On Aspen Aerogels, Inc.'s (NYSE:ASPN) Full-Year Report
Feb 15Powering Up The EV Market: Mini Deep Dive On Aspen Aerogels
Jan 08Why Investors Shouldn't Be Surprised By Aspen Aerogels, Inc.'s (NYSE:ASPN) 40% Share Price Surge
Dec 22Aspen Aerogels: Phoenix Rising - Assessing The Shifts, Challenges, And Potential Future Triumphs
Nov 13Aspen Aerogels (NYSE:ASPN) Is Making Moderate Use Of Debt
Nov 03Aspen Aerogels: Margin Expansion But Still A Lot Of Uncertainties
Sep 28The Price Is Right For Aspen Aerogels, Inc. (NYSE:ASPN) Even After Diving 25%
Aug 12Aspen Aerogels: Not Insulating Investors From The Cold
Jun 20Is Aspen Aerogels (NYSE:ASPN) Weighed On By Its Debt Load?
Feb 26Aspen Aerogels Q4 results beat estimates, co guides FY 2023 revenue in-line
Feb 15Aspen Aerogels: No Reason To Be In A Hurry, Ample Headwinds In 2023
Jan 08Aspen Aerogels (NYSE:ASPN) Has Debt But No Earnings; Should You Worry?
Oct 27Aspen Aerogels reports Q3 earnings miss; narrows FY22 earnings guidance
Oct 27Is Aspen Aerogels (NYSE:ASPN) A Risky Investment?
Jul 16Aspen Aerogels soars ~56% following its decision to not advance with stock and debt offering
Jun 30Aspen Aerogels: The Next Big Opportunity
Apr 28Aspen Aerogels: Highly Speculative
Feb 22Companies Like Aspen Aerogels (NYSE:ASPN) Are In A Position To Invest In Growth
Dec 24Is Aspen Aerogels, Inc. (NYSE:ASPN) Worth US$44.4 Based On Its Intrinsic Value?
Oct 24Is Aspen Aerogels (NYSE:ASPN) Using Too Much Debt?
Sep 28Revenue & Expenses BreakdownBeta
How Aspen Aerogels makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 239 | -46 | 90 | 16 |
| 30 Sep 23 | 214 | -55 | 85 | 16 |
| 30 Jun 23 | 190 | -71 | 78 | 17 |
| 31 Mar 23 | 188 | -80 | 74 | 17 |
| 31 Dec 22 | 180 | -83 | 67 | 17 |
| 30 Sep 22 | 152 | -89 | 59 | 16 |
| 30 Jun 22 | 146 | -68 | 53 | 14 |
| 31 Mar 22 | 132 | -50 | 45 | 13 |
| 31 Dec 21 | 122 | -37 | 39 | 11 |
| 30 Sep 21 | 113 | -27 | 35 | 10 |
| 30 Jun 21 | 107 | -26 | 30 | 9 |
| 31 Mar 21 | 100 | -25 | 28 | 9 |
| 31 Dec 20 | 100 | -22 | 27 | 9 |
| 30 Sep 20 | 124 | -17 | 29 | 9 |
| 30 Jun 20 | 135 | -12 | 31 | 9 |
| 31 Mar 20 | 140 | -12 | 31 | 9 |
| 31 Dec 19 | 139 | -15 | 32 | 8 |
| 30 Sep 19 | 129 | -28 | 33 | 8 |
| 30 Jun 19 | 117 | -32 | 32 | 7 |
| 31 Mar 19 | 109 | -34 | 33 | 7 |
| 31 Dec 18 | 104 | -34 | 33 | 6 |
| 30 Sep 18 | 105 | -22 | 30 | 6 |
| 30 Jun 18 | 108 | -19 | 30 | 6 |
| 31 Mar 18 | 112 | -17 | 30 | 6 |
| 31 Dec 17 | 112 | -19 | 32 | 6 |
| 30 Sep 17 | 103 | -23 | 32 | 6 |
| 30 Jun 17 | 105 | -23 | 33 | 6 |
| 31 Mar 17 | 108 | -19 | 32 | 6 |
| 31 Dec 16 | 118 | -12 | 29 | 5 |
| 30 Sep 16 | 127 | -5 | 28 | 5 |
| 30 Jun 16 | 129 | -4 | 27 | 5 |
| 31 Mar 16 | 132 | -5 | 27 | 5 |
| 31 Dec 15 | 123 | -6 | 26 | 5 |
| 30 Sep 15 | 113 | -11 | 25 | 6 |
| 30 Jun 15 | 107 | -11 | 25 | 6 |
| 31 Mar 15 | 104 | -50 | 28 | 6 |
| 31 Dec 14 | 102 | -66 | 27 | 6 |
| 30 Sep 14 | 99 | -64 | 26 | 6 |
| 30 Jun 14 | 95 | -75 | 27 | 6 |
| 31 Mar 14 | 91 | -40 | 22 | 5 |
| 31 Dec 13 | 86 | 1 | 22 | 5 |
Quality Earnings: ASPN is currently unprofitable.
Growing Profit Margin: ASPN is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ASPN is unprofitable, and losses have increased over the past 5 years at a rate of 27.1% per year.
Accelerating Growth: Unable to compare ASPN's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ASPN is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-7.3%).
Return on Equity
High ROE: ASPN has a negative Return on Equity (-9.39%), as it is currently unprofitable.